Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONTRAST: NAC and Bicarbonate for CIN Prevention in PCI
NCT00497328Phase 3Completed
- Sponsor
- National University Hospital
- Start
- Aug 2007
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine, sodium bicarbonate in contrast-induced nephropathy (CIN), sponsored by National University Hospital. Started Aug 2007; status: completed.
02
Drugs
acetylcysteinesodium bicarbonate
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT00497328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00497328.